149 related articles for article (PubMed ID: 3901534)
1. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
Kerjaschki D
Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
[TBL] [Abstract][Full Text] [Related]
2. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
3. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
5. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli.
Leung CC; Cheewatrakoolpong B; O'Mara T; Black M
Am J Anat; 1987 Jun; 179(2):169-74. PubMed ID: 3303894
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
[TBL] [Abstract][Full Text] [Related]
7. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
[TBL] [Abstract][Full Text] [Related]
8. Interaction of antibodies with human glomerular epithelial cells.
Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
[TBL] [Abstract][Full Text] [Related]
9. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
[TBL] [Abstract][Full Text] [Related]
10. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. IV. Investigations into the pathogenesis of the model.
Fleuren GJ; vd Lee R; Greben HA; Van Damme BJ; Hoedemaeker PJ
Lab Invest; 1978 Apr; 38(4):496-501. PubMed ID: 147960
[TBL] [Abstract][Full Text] [Related]
11. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
Verroust P; Ronco P
Nephrologie; 1989; 10(3):123-6. PubMed ID: 2691908
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity of a highly purified brush border membrane preparation in Heymann nephritis.
Chant S; Katz A; Silverman M
J Clin Lab Immunol; 1980 Nov; 4(3):133-40. PubMed ID: 6451709
[TBL] [Abstract][Full Text] [Related]
13. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
Kerjaschki D; Miettinen A; Farquhar MG
J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
[TBL] [Abstract][Full Text] [Related]
14. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
Singh AK; Kasinath BS
Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
[TBL] [Abstract][Full Text] [Related]
15. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G
J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408
[TBL] [Abstract][Full Text] [Related]
16. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
Natori Y; Hayakawa I; Shibata S
Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
[TBL] [Abstract][Full Text] [Related]
17. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
18. Alterations in glomerular anionic sites in autologous immune complex nephritis.
Schneeberger EE; Stavrakis G; McCarthy K
Lab Invest; 1983 Oct; 49(4):445-52. PubMed ID: 6620983
[TBL] [Abstract][Full Text] [Related]
19. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis.
Van Damme BJ; Fleuren GJ; Bakker WW; Vernier RL; Hoedemaeker PJ
Lab Invest; 1978 Apr; 38(4):502-10. PubMed ID: 147961
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antigen (gp600) of Heymann nephritis.
Makker SP; Singh AK
Lab Invest; 1984 Mar; 50(3):287-93. PubMed ID: 6199583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
